News
NITO
2.870
-3.69%
-0.110
Weekly Report: what happened at NITO last week (1124-1128)?
Weekly Report · 6d ago
Weekly Report: what happened at NITO last week (1117-1121)?
Weekly Report · 11/24 09:41
N2OFF shares update from CEO Silberman
TipRanks · 11/18 14:41
N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination
Barchart · 11/18 08:12
Weekly Report: what happened at NITO last week (1110-1114)?
Weekly Report · 11/17 09:41
Weekly Report: what happened at NITO last week (1103-1107)?
Weekly Report · 11/10 09:39
Weekly Report: what happened at NITO last week (1027-1031)?
Weekly Report · 11/03 09:39
N2OFF completes merger with MitoCareX Bio
TipRanks · 10/30 13:32
N2OFF COMPLETED MERGER WITH CANCER DRUG DISCOVERY COMPANY TARGETING TOUGH-TO-TREAT PANCREATIC AND LUNG CANCERS
Reuters · 10/30 13:25
*N2OFF Completes Merger With MitoCareX Bio Ltd. >NITO
Dow Jones · 10/30 13:25
*N2OFF Completed Merger With Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic And Lung Cancers >NITO
Dow Jones · 10/30 13:25
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
Barchart · 10/30 08:25
N2off Inc. Files Initial Statement of Beneficial Ownership; Dr. Alon Silberman Reported as 10% Owner
Reuters · 10/28 20:05
Weekly Report: what happened at NITO last week (1020-1024)?
Weekly Report · 10/27 09:41
N2off Inc. Discloses SciSparc Ltd. as 10% Owner in Initial Beneficial Ownership Filing
Reuters · 10/24 20:06
N2OFF Inc. Announces Date for Upcoming Annual Stockholders Meeting
Reuters · 10/24 13:01
N2OFF Finalizes Acquisition of MitoCareX Bio Ltd.
TipRanks · 10/23 20:40
SciSparc Closes Sale of MitoCareX to N2OFF
Reuters · 10/23 20:03
SCISPARC ANNOUNCES CLOSING OF THE SALE TO N2OFF OF MAJORITY-OWNED SUBSIDIARY MITOCAREX, ADVANCING DRUG DISCOVERY FOR RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL CELL LUNG CANCER
Reuters · 10/23 20:03
N2OFF Closes Merger with MitoCareX Bio
Reuters · 10/23 20:02
More
Webull provides a variety of real-time NITO stock news. You can receive the latest news about N2OFF INC through multiple platforms. This information may help you make smarter investment decisions.
About NITO
N2OFF, Inc. is a cleantech company mainly engaged in European Union (EU) based solar assets using the Ready to Build (RTB) business model. The Company is an investor in four solar projects in three different EU countries. It collaborates with Solterra Renewable Energy Ltd., an Israeli corporation and a wholly owned subsidiary of Solterra Energy Ltd., an Israeli corporation, which operates in the solar energy sector and presents certain investment opportunities in solar photovoltaic (PV) projects. The Company also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. The Company’s solutions are focused on improving the food safety and shelf life of fresh produce. The Company, through its subsidiary, MitoCareX Bio Ltd., is focused on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family.